LONDON (Reuters) – AstraZeneca (NASDAQ:AZN)’s lung cancer therapy, Tagrisso, cut the risk of death by more than half in patients with a certain form of lung cancer who were diagnosed…
Trending News
April 4, 2026
April 3, 2026
April 3, 2026
April 3, 2026





